期刊文献+

核酶抗肿瘤/抗病毒研究进展 被引量:1

下载PDF
导出
摘要 核酶作为一种新型的靶向基因药物,主要针对基因表达发挥作用,为抗肿瘤和抗病毒治疗提供了新的方法。它具有特异性高的特点,目前对于它的研究还刚刚起步。现将核酶在抗肿瘤、抗病毒中的研究状况作一综述。
出处 《检验医学与临床》 CAS 2005年第2期77-79,共3页 Laboratory Medicine and Clinic
  • 相关文献

参考文献4

二级参考文献30

  • 1Cesar C, Isidro Sanchez-Garcia. RNase P: from biological function to biotechnological applications, Trends in Biotechnology, 2001,19 (10):406~411. 被引量:1
  • 2Phong T,Manfred L,Edward N,et al.Effective inhibition of human cytomegalovirus gene expression and replication by a ribozyme derived from the catalytic RNA subtmit of RNase P from Escherichia coll. PNAS ,2000,97( 11 ) :5812 ~ 5817. 被引量:1
  • 3Jeffrey MclGnney, Cecilia GT, Donna W, et al. Inhibition of Escherichia coil viability by external guide sequences complementary to two essential genes, PNAS, 2001,98 (12) : 6605~ 6610. 被引量:1
  • 4Ying Li, Cecilia G T,Sidney A.Targeted cleavage of mRNA in vitro by RNase P from Escherichia coli .Proc Nail Acad Sci USA,1992 (89) :3185 ~ 3189. 被引量:1
  • 5Phong T, Amy W, Liu Fenyong. Nuclease footprint analyses of the interactions between RNnse P ribozyme and a model mRNA substrate. Nucleic Acids Research, 1999,27 (23) :4590 ~ 4597. 被引量:1
  • 6Walter D,Phong T,Umair K,et al. RNase P-mediated inhibition of cytomegalovirus protease expression and viral DNA encapsidation by oligonucleotide external guide sequences, Proc Natl Acad Sci USA. 2001,98(26) : 14831 ~ 14836. 被引量:1
  • 7Strid S, Ribonuclease P: the diversity of a ubiquitous RNA processing enzyme. FEMS Microbiology Reviews, 1999 ( 23 ) : 391~406. 被引量:1
  • 8Tanner N K. Ribozynes: the characteristics and properties of catalytic RNAs. FEMS Microbiology Reviews, 1999 (23) : 257 ~275. 被引量:1
  • 9Spaete R R, Gehrz R, Landini M P, et al. Human cytomegalovirus structural proteins.J Gen Virol, 1994(75) :3287 ~ 3308. 被引量:1
  • 10Diane K, Wang .Tun, Yah Yuan, et al. Inhibition of viral gene expression by human ribonuclease P. RNA, 1998 (4) : 1397 ~1406. 被引量:1

共引文献19

同被引文献49

  • 1邵宁生,李少华,黄燕苹.SELEX技术及Aptamer研究的新进展[J].生物化学与生物物理进展,2006,33(4):329-335. 被引量:19
  • 2Saksmerprome V,Rovchowdhury-Saha M,Jayasena S,et al.Artificial tertiary motifs stabilize trans-cleaving hammerhead ribozymes under conditions of submillimolar divalent ions and high temperatures[J].RNA,2004,10(12):1916-1924 被引量:1
  • 3Chang Z,Westaway S,Li S,et al.Enhanced expression and HIV-1 inhibition of chimeric tRNA(Lys3)-ribozymes under dual U6 snRNA and tRNA promoters[J].Mol Ther,2002,6(4):481-489 被引量:1
  • 4Wang DY,Sen D.Rationally designed allosteric variants of hammerhead ribozymes responsive to the HIV-1 Tat protein[J].Comb Chem High Throughput Screen,2002,5(4):301-312 被引量:1
  • 5Neff T,Peterson LJ,Morris JC,et al.Efficient gene transfer to hematopeietic repopulatiag cells using concentrated RDl14-pseudotype vectors produced by human packaging cells[J].Mol Ther,2004,9(2):157-159 被引量:1
  • 6Waninger S,Knhen K,Hu X,et al.Identification of celluar cofactors for human immunodeficiency virus replication via a ribozymo-based genomics approach[J].J Virol,2004,78(23):12829-12837 被引量:1
  • 7Li MJ,Kim J,Li S,et at.Long-term inhibition of HIV-1 infection in primary hematopoietic cells by lentiviral vector delivery of a triple combination of anti-HIV shRNA,anti-CCR5 rilbozyme,and a nucleolarlecalizing TAR decoy[J].Mol Ther,2005,12(5):900-909 被引量:1
  • 8Konopka K,Lee NS,Rossi J,et al.Rev-binding aptamer and CMV promoter act as decoys to inhibit HIV replication[J].Gene,2000,255(2):235-244 被引量:1
  • 9RamezaniA,Ma XZ,Ameli M,et al.Assessment of an anti-HIV-1 combination gene therapy strategy using the antiaense RNA and multimeric hammerhcad ribozymes[J].Front Biosci,2006,11:2940-2948 被引量:1
  • 10Wong-Staal F,Poeschla EM,Looney DJ.A controlled,Phase 1 clinical trial to evaluate the safety and effects in HIV-1 infected humans of autologous lymphecytes transduced with a ribozyme that cleaves HIV-1 RNA[J].Hum Gene Ther,1998,9(16):2407-2425 被引量:1

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部